Skip to main content
. 2022 Jun 23;19(13):7717. doi: 10.3390/ijerph19137717

Table 1.

Occurrence of selected NSAIDs in surface water, wastewater and drinking/underground water in different locations.

Surface Water (ng/L) Reference Wastewater (Effluents (E)/Influents (I)) (ng/L) Reference Drinking Water (DW)/Underground Water (UW) (ng/L) Reference Area
Ibuprofen
<0.3–56.0
3730.1
222.0
2.2
0.0−346.0
21.0–2796.0
0.9−115.8
 
0.1−0.6
524.0−17,600.0
[42]
[43]
[44]
[45]
[46]
[47]
[48]
 
[49]
[50]
 
31,250.0
0−4926.0 (I)
 
20,130.0
0−10,600.0 (E)
 
 
0.2−1.9
 
 
[43]
[44]
 
[46]
[51]
 
 
[49]
 

223.6 (UW)/599.0 (DW)
ND−1.2
 
92
5850.0
<LOD−17.2
7.0−836.7

 
[43]
[51]
 
 
[51]
[52]
[53]

UK
Poland
Portugal
Sweden
Serbia
North America
China
Taiwan
Vietnam
South Africa
Diclofenac
<0.5–261.0
5401.5
241.0
1.7−3.6
0−324
17.0–42.0
ND−1.5
 
0.3−0.4
1010.0−10,200.0
[42]
[43]
[54]
[45]
[46]
[47]
[48]
 
[49]
[50]
 
40,570.2
0–269.0 (I)
 
1338.0
 
 
286.0
0.1−1.0
 
[43]
[44]
 
[46]
 
 
[55]
[49]
 
2770.0 (GW)/114.3 (DW)
 
 
 
 
<LOD−2.4
2.1−33.2
 
[43]
 
 
 
 
[52]
[53]
UK
Poland
Portugal
Sweden
Serbia
North America
China
Taiwan
Vietnam
South Africa
Naproxen
<0.3–55.0
1091.9
178.0
0.2
0−74.2
22.0
3.5
 
0.1−0.4
59,300.0
[42]
[43]
[54]
[45]
[46]
[47]
[56]
 
[49]
[50]
 
551,960.0
8.8−1617.0 (I)
 
208.0
23,210.0 (I)
 
470.0
0.1−0.6
 
[43]
[44]
 
[46]
 
 
[57]
[55]
[49]
 
21.0 (GW)/13.0 (DW) 
 
 
27.6 
44.0 
<LOD−3.1 
128.0
 
[43]
 
 
[46]
[58]
[52]
[53]
UK
Poland
Portugal
Sweden
Serbia
North America
China
Taiwan
Vietnam
South Africa
Ketoprofen
<0.5–4.0
132.2
0.3−89.0
0.3−1.3
1.4−54.5
509
<0.5−0.5
443.0−9220.0
[42]
[43]
[54]
[45]
[59]
[60]
[49]
[50]
 
233,630.0
289.0−589.0 (I)
 
247.0
 
0.1−1.6
 
[43]
[44
[46]
 
[49]
 
731.8 (GW)/166.9 (DW)
0.09
 
16.0 (DW)
4.1 (GW)
ND
 
[43]
[61]
[46]
 
[62]
[63]
UK
Poland
Portugal
Sweden
Serbia
China
Vietnam
South Africa

<LOD = below limit of detection; ND = non detected.